149 related articles for article (PubMed ID: 34233509)
1. Impact of double reading on NI-RADS diagnostic accuracy in reporting oral squamous cell carcinoma surveillance imaging - a single-center study.
Elsholtz FHJ; Ro SR; Shnayien S; Dinkelborg P; Hamm B; Schaafs LA
Dentomaxillofac Radiol; 2022 Jan; 51(1):20210168. PubMed ID: 34233509
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI.
Dinkelborg P; Ro SR; Shnayien S; Schaafs LA; Koerdt S; Kreutzer K; Heiland M; Hamm B; Elsholtz FHJ
AJR Am J Roentgenol; 2021 Jul; 217(1):198-206. PubMed ID: 32876497
[No Abstract] [Full Text] [Related]
3. Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.
Jajodia A; Mandal G; Yadav V; Khoda J; Goyal J; Pasricha S; Puri S; Dewan A
AJNR Am J Neuroradiol; 2022 Jul; 43(7):1018-1023. PubMed ID: 35738671
[TBL] [Abstract][Full Text] [Related]
4. Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.
Johansson ED; Hughes RT; Meegalla NT; Porosnicu M; Patwa HS; Lack CM; Bunch PM
Laryngoscope; 2022 Sep; 132(9):1792-1797. PubMed ID: 35043989
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of NI-RADS for prediction of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Li W; Sun Y; Shang W; Xu H; Zhang H; Lu F
Radiol Med; 2024 Jan; 129(1):70-79. PubMed ID: 37904037
[TBL] [Abstract][Full Text] [Related]
6. Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Baba A; Kurokawa R; Kurokawa M; Yanagisawa T; Srinivasan A
AJNR Am J Neuroradiol; 2023 Oct; 44(10):1184-1190. PubMed ID: 37709352
[TBL] [Abstract][Full Text] [Related]
7. Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Krieger DA; Hudgins PA; Nayak GK; Baugnon KL; Corey AS; Patel MR; Beitler JJ; Saba NF; Liu Y; Aiken AH
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1193-1199. PubMed ID: 28364010
[TBL] [Abstract][Full Text] [Related]
8. Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.
Hsu D; Rath TJ; Branstetter BF; Anzai Y; Phillips CD; Juliano AF; Mosier KM; Bazylewicz MP; Poliashenko SM; Kulzer MH; Rhyner PA; Risk B; Wiggins RH; Aiken AH
Radiol Imaging Cancer; 2021 May; 3(3):e200131. PubMed ID: 34018845
[TBL] [Abstract][Full Text] [Related]
9. MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.
Ashour MM; Darwish EAF; Fahiem RM; Abdelaziz TT
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1123-1129. PubMed ID: 33707288
[TBL] [Abstract][Full Text] [Related]
10. NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Baugnon KL
Neuroimaging Clin N Am; 2022 Feb; 32(1):1-18. PubMed ID: 34809832
[TBL] [Abstract][Full Text] [Related]
11. Initial Referring Physician and Radiologist Experience with Neck Imaging Reporting and Data System.
Bunch PM; Meegalla NT; Abualruz AR; Frizzell BA; Patwa HS; Porosnicu M; Williams DW; Aiken AH; Hughes RT
Laryngoscope; 2022 Feb; 132(2):349-355. PubMed ID: 34272871
[TBL] [Abstract][Full Text] [Related]
12. Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC).
Abdelaziz TT; Abdel Razk AAK; Ashour MMM; Abdelrahman AS
Cancer Imaging; 2020 Aug; 20(1):61. PubMed ID: 32811559
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer.
Hsu D; Chokshi FH; Hudgins PA; Kundu S; Beitler JJ; Patel MR; Aiken AH
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):978-985. PubMed ID: 31331239
[TBL] [Abstract][Full Text] [Related]
14. Reliability of NI-RADS criteria in the interpretation of contrast-enhanced magnetic resonance imaging considering the potential role of diffusion-weighted imaging.
Elsholtz FHJ; Erxleben C; Bauknecht HC; Dinkelborg P; Kreutzer K; Hamm B; Niehues SM
Eur Radiol; 2021 Aug; 31(8):6295-6304. PubMed ID: 33533989
[TBL] [Abstract][Full Text] [Related]
15. Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Wangaryattawanich P; Branstetter BF; Hughes M; Clump DA; Heron DE; Rath TJ
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1884-1888. PubMed ID: 30166429
[TBL] [Abstract][Full Text] [Related]
16. NI-RADS for head and neck cancer surveillance imaging: What, why, and how.
Juliano AF; Aiken AH
Cancer Cytopathol; 2020 Mar; 128(3):166-170. PubMed ID: 31750995
[TBL] [Abstract][Full Text] [Related]
17. Best Practices: Application of NI-RADS for Posttreatment Surveillance Imaging of Head and Neck Cancer.
Strauss SB; Aiken AH; Lantos JE; Phillips CD
AJR Am J Roentgenol; 2021 Jun; 216(6):1438-1451. PubMed ID: 32876470
[TBL] [Abstract][Full Text] [Related]
18. Neck Imaging Reporting and Data System: What Does Radiologist Want to Know?
Abdel Razek AAK; Abdelaziz TT
J Comput Assist Tomogr; 2020; 44(4):527-532. PubMed ID: 32467486
[TBL] [Abstract][Full Text] [Related]
19. Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
Lee J; Kaht D; Ali S; Johnson S; Bullen J; Karakasis C; Lamarre E; Geiger J; Koyfman S; Stock S
Head Neck; 2022 Oct; 44(10):2257-2264. PubMed ID: 35801334
[TBL] [Abstract][Full Text] [Related]
20. Neck Imaging Reporting and Data System.
Aiken AH; Hudgins PA
Magn Reson Imaging Clin N Am; 2018 Feb; 26(1):51-62. PubMed ID: 29128006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
